Recall: MAR-Amlodipine bottles may contain the wrong medication

Health Canada says Marcan Pharmaceuticals is recalling two lots of MAR-Amlodipine 5 mg because some bottles may contain midodrine 2.5 mg tablets; officials are monitoring the recall and advising checks of affected bottles.

Health Canada announced a recall by Marcan Pharmaceuticals of two lots of MAR-Amlodipine 5 mg after some bottles were identified as possibly containing midodrine 2.5 mg tablets. MAR-Amlodipine is used for high blood pressure and chest pain, while midodrine is used to raise low blood pressure. Officials said substituting those drugs can lead to a dangerous increase in blood pressure and other serious effects. Health Canada is monitoring the company's recall and investigation. Key points: - The recall was issued because some bottles labeled MAR-Amlodipine 5 mg may contain midodrine 2.5 mg tablets, according to the advisory. - Health Canada said it is monitoring the company's recall and corrective actions and will inform the public if new health risks are identified. - The advisory described visual differences: the correct MAR-Amlodipine tablets are white to off-white, eight-sided with "210" and "5" on one side; the incorrect tablets are round and marked "M2." - Officials reported that the advisory advised consumers to check bottles and return those with round tablets, and that health-care professionals should check packages and bottles of MAR-Amlodipine 5 mg. Summary: This recall follows reports that some bottles labelled as MAR-Amlodipine 5 mg may contain midodrine 2.5 mg, which can raise blood pressure. Health Canada is monitoring the recall and the company's investigation and said it will notify the public if any new health risks are identified.